Clinical Study

A Study Of Exenatide For Weight Gain Associated With Olanzapine.

Posted Date: Aug 3, 2016

  • Investigator: Melissa Delbello
  • Co-Investigator: Karen Parker
  • Specialties:
  • Type of Study: Drug

This is a research study to evaluate whether a medication commonly used to treat diabetes can reduce weight gain associated with Zyprexa. The study drug is not approved by the U.S. FDA for weight loss and is considered investigational. Study participants

Criteria:

Adults 18 To 55 Years Old Who Have Gained Weight While Taking Zyprexa May Be Eligible To Participate.

Keywords:

Olanzapine, Overweight, Symbyax, Weight Gain, Zyprexa

For More Information:

Emily Rummelhoff
(513) 558-4295
emily.rummelhoff@uc.edu

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.